M
Mary Brophy
Researcher at VA Boston Healthcare System
Publications - 119
Citations - 6685
Mary Brophy is an academic researcher from VA Boston Healthcare System. The author has contributed to research in topics: Veterans Affairs & Medicine. The author has an hindex of 28, co-authored 83 publications receiving 5242 citations. Previous affiliations of Mary Brophy include Stanford University & Boston University.
Papers
More filters
Journal ArticleDOI
Intensity of renal support in critically ill patients with acute kidney injury
Paul M. Palevsky,Jane Hongyuan Zhang,Theresa Z. O'Connor,Glenn M. Chertow,Susan T. Crowley,Devasmita Choudhury,Kevin W. Finkel,John A. Kellum,Emil P. Paganini,Roland M. H. Schein,Mark W. Smith,Kathleen M. Swanson,B. Taylor Thompson,Anitha Vijayan,Suzanne Watnick,Robert A. Star,Peter Peduzzi,E. Young,R. Fissel,W. Fissel,Uptal D. Patel,K. Belanger,A. Raine,N. Ricci,James B. Lohr,P. Arora,D. Cloen,D. Wassel,L. Yohe,J. Amanzadeh,J. Penfield,M. Hussain,R. Katneni,A. Sajgure,A. Swann,G. Dolson,V. Ramanathan,G. Tasby,Robert L. Bacallao,M. Jaradat,Kenneth Edward Graves,Q. Li,M. Krause,M. Shaver,M. Alam,K. Morris,T. Bland,E. Satter,Jeffrey A. Kraut,A. Felsenfeld,B. Levine,G. Nagami,B. Vaghaiwalla,J. Duffney,Joseph O. Moore,C. Cely,E. Jaimes,Daniel H. Kett,Andrew A. Quartin,M. Arcia,A. Barchi-Chung,Vecihi Batuman,A. Alper,A. Dreisbach,E. Simon,C. Kulivan,Nabeel Aslam,M.C. Ramkumar,E. Grum,P. Rogers,Steven D. Weisbord,C. Geffel,Ihab M. Wahba,Darren J. Kelly,J. Walczyk,George Feldman,A. Mogyorosi,G. Viol,M. Halverson,S. Schmid,H. Totten,Francis B. Gabbai,S. Mullaney,R. Smith,J. Dingsdale,S. Woods,Kirsten L. Johansen,David H. Lovett,Ann M. O’Hare,James T. McCarthy,C. Rosado-Rodriguez,A. Galera,G. Rodriguez-Vega,W. Rodriguez,C. Vilchez,B. Young,Dennis L. Andress,A. Lindner,G. Galvin,N. Gourley,Aldo J. Peixoto,M. Perkal,C. Joncas,Sevag Demirjian,J. Yared,R. Brienza,M. Garcia,T. Seifert,L. Sweeney,Hamid Rabb,Mohamed G. Atta,Roy G. Brower,M. Choi,Joseph A. Eustace,Paul J. Scheel,E. Heck,H. Rahman,John L. Niles,H. Bazari,K. Smirnakis,D. Steele,Ravi Thadhani,K. Laliberte,B. Leeman,C. McCarthy,M. Pescatore,Harold M. Szerlip,P. Fall,M. Jagadeesan,Laura L Mulloy,William D Paulson,J. White,N. Sickafoose,K. Cho,M. Gropper,K. Liu,Michael A. Matthay,K. Borovitz,M. Koenigsberg,S. Rodriguez,Gabriel Contreras,S. Cohn,J. Diego,C. Carvalho,D. Carvalho,M. Castro,C. de la Cuesta,I. Espinal,A. Hurtado,P. Oyuela,Mark Unruh,Renee Burr,Michael P. Donahoe,J. Marszalek,M. Shields,R. Venkataraman,J. Aubrecht,H. Sterling,L. Mandich,A. Shaw,J. Foringer,J. Samuels,B. Efron,Michael V. Rocco,E. Deterding,Shahriar Moossavi,C. Bethea,D. McBride,Stuart R. Warren,M. Kollef,K. Sambandam,E. Hammer,M. Hoffman,John B. Stokes,Alfred F. Connors,Harold I. Feldman,Joel W. Greer,G. G. Koch,Thomas E. Stewart,Janet Wittes,P. Overberger,S. Michler,Massimo Antonelli,K. Dellert,L. Durant,R. Franchini,A. Kossack,V. McBride,S. O'Neil,Taposh Roy,J. Russo,Joseph N. Vitale,Mike R. Sather,C. Fye,C. M. Haakenson,D. H. Krueger,J. Thornton,C. Dalzell,R. Horney,Andrew M. Siroka,P. Su,Mary Brophy,D. Humphries,D. Govan,Timothy J. O'Leary,G. D. Huang,John R. Feussner,Paul W. Eggers +207 more
TL;DR: Intensive renal support in critically ill patients with acute kidney injury did not decrease mortality, improve recovery of kidney function, or reduce the rate of nonrenal organ failure as compared with less-intensive therapy.
Journal ArticleDOI
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried,Nicholas V. Emanuele,Nicholas V. Emanuele,Jane H. Zhang,Mary Brophy,Todd A. Conner,William C. Duckworth,William C. Duckworth,David J. Leehey,David J. Leehey,Peter A. McCullough,Theresa Z. O'Connor,Paul M. Palevsky,Robert F. Reilly,Stephen L. Seliger,Stuart R. Warren,Suzanne Watnick,Peter Peduzzi,Peter Peduzzi,Peter Guarino +19 more
TL;DR: Combination therapy with an ACE inhibitor and an ARB was associated with an increased risk of adverse events among patients with diabetic nephropathy and safety outcomes included mortality, hyperkalemia, and acute kidney injury.
Journal ArticleDOI
Million Veteran Program: A mega-biobank to study genetic influences on health and disease.
John Michael Gaziano,John Michael Gaziano,John Concato,Mary Brophy,Mary Brophy,Louis D. Fiore,Louis D. Fiore,Saiju Pyarajan,James Breeling,Stacey B. Whitbourne,Jennifer Deen,Colleen Shannon,Donald E. Humphries,Peter Guarino,Mihaela Aslan,Daniel Anderson,Rene LaFleur,Timothy R. Hammond,Kendra L. Schaa,Jennifer Moser,Grant D. Huang,Sumitra Muralidhar,Ronald M. Przygodzki,Timothy J. O'Leary +23 more
TL;DR: The Million Veteran Program, as an observational cohort study and mega-biobank in the Department of Veterans Affairs (VA) health care system, is designed to contribute to the development of precision medicine.
Journal ArticleDOI
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine
Steven D. Weisbord,Martin Gallagher,Martin Gallagher,Hani Jneid,Santiago Garcia,Alan Cass,Alan Cass,Soe Soe Thwin,Todd A. Conner,Glenn M. Chertow,Deepak L. Bhatt,Kendrick A. Shunk,Chirag R. Parikh,Edward O. McFalls,Mary Brophy,Ryan Ferguson,Hongsheng Wu,Maria Androsenko,John Myles,James C. Kaufman,Paul M. Palevsky +20 more
TL;DR: Among patients at high risk for renal complications who were undergoing angiography, there was no benefit of intravenous Sodium bicarbonate over intravenous sodium chloride or of oral acetylcysteine over placebo for the prevention of death, need for dialysis, or persistent decline in kidney function at 90 days.
Journal ArticleDOI
Therapies for active rheumatoid arthritis after methotrexate failure
James R O’Dell,Ted R. Mikuls,Thomas Taylor,Vandana Ahluwalia,Mary Brophy,Stuart R. Warren,Robert A. Lew,Amy C. Cannella,Gary Kunkel,Ciaran S. Phibbs,Ciaran S. Phibbs,Aslam H. Anis,Sarah Leatherman,Edward C. Keystone +13 more
TL;DR: Triple therapy, with sulfasalazine and hydroxychloroquine added to methotrexate was noninferior to etanercept plus metotrexate in patients with rheumatoid arthritis who had active disease despite methotRexate therapy.